"UPMC Magee-Womens Hospital is a Maternity Hospital located in Pittsburgh.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, Magee-Women's Hospital, Department of Obstetrics and Gynecology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Magee-Women's Hospital, Department of Obstetrics and Gynecology" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator, "Duke University" with 3 trials as a collaborator, "Kaiser Permanente" with 3 trials as a collaborator, "RTI International" with 3 trials as a collaborator and "University of Alabama at Birmingham" with 3 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Magee-Women's Hospital, Department of Obstetrics and Gynecology" are "Urinary Incontinence, Stress" (2 trials), "Urinary Incontinence, Urge" (2 trials), "Abruptio Placentae" (1 trials), "Bowel Incontinence" (1 trials) and "Cerebral Palsy" (1 trials). Many other conditions were trialed in "Magee-Women's Hospital, Department of Obstetrics and Gynecology" in a lesser frequency.

Most popular intervention types in "Magee-Women's Hospital, Department of Obstetrics and Gynecology" are "Drug" (3 trials), "Device" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Betamethasone" (1 trials), "Botox® injection" (1 trials), "ES-130" (1 trials), "Mid-urethral sling" (1 trials) and "Miduretheral Sling" (1 trials). Other intervention names were less common.

The vast majority of trials in "Magee-Women's Hospital, Department of Obstetrics and Gynecology" are 6 trials for "Female" genders.

Currently, there are NaN active trials in "Magee-Women's Hospital, Department of Obstetrics and Gynecology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Magee-Women's Hospital, Department of Obstetrics and Gynecology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Magee-Women's Hospital, Department of Obstetrics and Gynecology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".